Skip to Main Content
1-877-YALEMDS
SpecialistsFact SheetsDepartmentsClinical TrialsNewsPatient ToolsFor Medical Professionals
1-877-YALEMDS
  • Search
  • Clinical Trials
  • Cervical Cancer Genomics

Clinical Trials

    • Cancer(5)
  • Colorectal Cancer, Gynecological Cancers, Pancreatic Cancer, Prostate Cancer, Breast Cancer

    PROgram to address psychosocial Support, clinical outcomes, and genomic insights for Patients with EaRly onset cancers

    • Gynecological Cancers

      A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

      • GenderFemale only
    • Phase 1 Cancers

      A Phase 1, First-in-Human Study of CUSP06, a Cadherin-6 (CDH6)-Directed Antibody-Drug Conjugate, in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

      • Gynecological Cancers

        A Randomized Phase 2 Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer

        • Ages18 years - 99 years
        • GenderFemale only
      • Phase 1 Cancers

        A Phase 1 Study to Evaluate the Safety and Tolerability of GS-9911 as Monotherapy and in Combination With an Anti-PD-1 Monoclonal Antibody in Adults With Advanced Solid Tumors

        • About Us
        • Contact Us
        • Donate
        • Referring Doctors
        • Clinical Keywords

        333 Cedar St.

        New Haven, CT 06510

        • Yale School of Medicine
        • Yale University
        • Terms & Privacy Policies
        • Accessibility at YSM
        • Patient Rights
        • HIPAA at Yale
        • Non-discrimination Statement
        Copyright 2025 Yale Medicine